ABOUT
ABOUT DURECT
MANAGEMENT
BOARD OF DIRECTORS
CORPORATE GOVERNANCE
BOARD COMMITTEE CHARTERS
CODE OF ETHICS
WHISTLEBLOWER POLICY
CORPORATE GOVERNANCE GUIDELINES
PRODUCTS
ALZET® Osmotic Pumps
LACTEL® Absorbable Polymers
PIPELINE
OVERVIEW
IN DEVELOPMENT
DUR-928
POSIMIR® (bupivacaine extended-release solution)
ORADUR® -Methylphenidate ER
SUSTAINED-RELEASE Ophthalmology Product
SCIENCE & TECHNOLOGIES
EPIGENETIC REGULATORS
LONG-ACTING INJECTABLES
SABER® PLATFORM
CLOUD® PLATFORM
ORADUR® ABUSE-DETERRENT TECHNOLOGY
TRANSDUR® TRANSDERMAL TECHNOLOGY
PATENTS
PUBLICATIONS
POSIMIR® (SABER® -Bupivacaine)
EPIGENETIC REGULATOR PROGRAM
SABER® & CLOUD® Injectable Depot Systems
INVESTORS
OVERVIEW
STOCK INFORMATION
NEWS RELEASES
COLLABORATIONS
EARNINGS ESTIMATE
ANALYST COVERAGE
CORPORATE PRESENTATION
FINANCIAL REPORTS
SEC FILINGS
EVENT CALENDAR
FAQs
EMAIL ALERTS
INFORMATION REQUEST
NEWS
NEWS RELEASES
MEDIA KIT
INVESTORS
Overview
Corporate Factsheet
Stock Information
News Releases
Collaborations
Earnings Estimate
Analyst Coverage
Corporate Presentation
Financial Reports
SEC Filings
Event Calendar
FAQs
E-mail Alerts
Information Request
Other Reports
Annual Reports
Other Reports
Date
Title
03/03/15
DURECT 2014 10-K
02/28/14
DURECT 2013 10-K
03/01/13
DURECT 2012 10-K
03/02/12
DURECT 2011 10-K
03/03/11
DURECT 2010 10-K
Get help downloading or viewing the above file types
© 2000- DURECT Corporation
BUSINESS DEVELOPMENT
|
CAREERS
|
CONTACT
|
LEGAL NOTICE
|
PRIVACY POLICY